AIDS-Science Track Award for Research Transition (R03 Clinical Trial Optional)
ID: 335646Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $1M

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/335646

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAS-21-270.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering the AIDS-Science Track Award for Research Transition (A-START), a federal grant aimed at facilitating the entry of early-stage investigators into research that integrates substance use disorders (SUD) with HIV/AIDS. This funding opportunity encourages applications for Small Research Grant (R03) projects that can be completed within two years, with budgets up to $100,000 annually, focusing on critical areas such as epidemiology, intervention strategies, and health disparities affecting substance users. The total funding available for this initiative is approximately $1,000,000, with an estimated 12 awards anticipated for fiscal year 2022. Interested applicants must submit their proposals by January 7 each year and can reach out to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries or guidance.

    Point(s) of Contact
    OERWebmaster03@od.nih.gov
    Files
    Title
    Posted
    PAS-21-270-Full-Announcement.html
    PAS-21-270.html
    The National Institutes of Health (NIH) invites applications for the AIDS-Science Track Award for Research Transition (A-START) to facilitate early-stage investigators' entry into research integrating substance use disorders (SUD) with HIV/AIDS. This funding opportunity, under the R03 Small Grant Program, offers approximately $1,000,000 for an estimated 12 awards in fiscal year 2022, supporting projects that can be completed in two years with budgets up to $100,000 annually. Applications are encouraged that address topics like epidemiology, novel intervention strategies, and health disparities affecting substance users in relation to HIV/AIDS. The deadline for application submissions is consistently January 7 yearly. Eligibility includes higher education institutions, nonprofits, and foreign entities, with a strong focus on diversity and inclusion. Applicants must adhere to specific registration and submission processes through NIH's online systems, ensuring compliance with guidelines outlined in the NIH Grants Policy Statement. This FOA aims to advance understanding and research in areas critical for achieving public health targets related to HIV and SUD, promoting innovative solutions to social and health challenges faced by marginalized populations.
    Similar Opportunities
    D-START: Data Science Track Award for Research Transition (D/START) (R03-Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the D-START: Data Science Track Award for Research Transition (D/START), a federal grant aimed at supporting small research projects that utilize advanced data science techniques to address critical issues related to substance use and substance use disorders. This funding opportunity encourages investigators, particularly those newly entering the field or established researchers incorporating novel methodologies, to propose projects that can be executed quickly and efficiently, including pilot studies and secondary analyses of existing datasets. Grants of up to $100,000 per project per year are available for a maximum of two years, with a total of six to seven awards anticipated annually. Interested applicants should adhere to the application guidelines outlined in the NIH Application Guide, with the earliest submission date set for September 16, 2024, and applications due by 5:00 PM local time. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)" aimed at supporting innovative research that addresses the intersection of HIV and substance use. This initiative invites applications from individual researchers and research teams to develop projects that can lead to new prevention, treatment, and care strategies for individuals affected by both conditions, with a requirement for a detailed research plan and preliminary data. A total budget of $3.0 million is available for funding one to two awards, with individual project budgets capped at $1.5 million per fiscal year, and applications are due by February 12, 2027. Interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries and are encouraged to consult with NIDA program staff early in the application process.
    Exploratory Studies to Investigate Mechanisms of HIV infection, Replication, Latency, and/or Pathogenesis in the Context of Substance Use Disorders (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Exploratory Studies to Investigate Mechanisms of HIV infection, Replication, Latency, and/or Pathogenesis in the Context of Substance Use Disorders" through the R01 Research Project Grant. This initiative aims to support innovative and high-risk studies that explore the molecular mechanisms linking HIV and substance use disorders (SUDs), with a focus on advancing understanding of HIV dynamics within the Central Nervous System (CNS). The total estimated program funding is $2 million for fiscal year 2026, with the potential to support up to three awards, and applications must include clear milestones and human or primate studies. Interested applicants should note that the deadline for submitting letters of intent and applications is July 14, 2025, and no clinical trials are permitted under this grant. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)" aimed at supporting innovative research at the intersection of HIV and substance use. This initiative seeks proposals that address critical gaps in understanding and improving health outcomes for individuals living with HIV who also face substance use disorders, requiring detailed research plans and preliminary data from both individual researchers and research teams. NIH plans to allocate approximately $3 million annually for three to five awards over three years, with applications due by January 11, 2025, and a strong emphasis on enhancing diverse perspectives through an inclusion plan. For further inquiries, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-024.html.
    Imaging - Science Track Award for Research Transition (I/START) (R03- Basic Experimental Studies with Humans Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the Imaging - Science Track Award for Research Transition (I/START) grant opportunity, aimed at supporting small research projects in the field of neuroimaging, particularly related to substance use and addiction. This funding initiative encourages both new and established investigators to conduct "proof of concept" studies that can generate pilot data within a short timeframe and with limited resources. Eligible applicants include a diverse range of organizations, such as historically black colleges and universities, tribal governments, and faith-based organizations, with funding of up to $150,000 available for projects lasting a maximum of one year. Interested parties should submit their applications by January 8, 2025, and can reach out to the NIH OER Webmaster at grantsinfo@nih.gov for further assistance.
    Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Imaging - Science Track Award for Research Transition (I/START)" aimed at advancing neuroimaging methodologies relevant to substance use disorder (SUD) research. This program encourages both new and established investigators to conduct small "proof-of-concept" studies within a one-year project period, with a funding ceiling of $150,000. The initiative is designed to lower barriers for researchers in adopting advanced imaging techniques, thereby contributing to significant advancements in understanding and addressing substance use challenges. Interested applicants can find more information and application details at the provided link, with the application deadline set for January 7, 2028.
    Exploratory studies to investigate mechanisms of HIV infection, replication, latency, and/or pathogenesis in the context of substance use disorders (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for exploratory studies focused on the mechanisms of HIV infection, replication, latency, and pathogenesis in the context of substance use disorders (SUDs). This initiative aims to support high-risk, high-impact research that utilizes innovative tools to investigate the interactions between HIV and addictive substances, with a particular emphasis on understanding the molecular mechanisms involved and the effects of these substances on HIV latency and replication. The total funding budget for this opportunity is $2 million, intended to support three awards, each capped at $700,000 in direct costs annually. Applications are due by July 14, 2024, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. For more details, please refer to the full announcement available at https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-011.html.
    Imaging - Science Track Award for Research Transition (I/START) (R03- Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Imaging - Science Track Award for Research Transition (I/START) funding opportunity, aimed at supporting small research grants (R03) in the field of neuroimaging, particularly related to substance use and substance use disorders. This initiative encourages both early-career and established researchers to adopt brain imaging methodologies for "proof of concept" studies, which are essential for generating preliminary data necessary for larger research applications. Grants of up to $150,000 are available for a one-year period, with a focus on inclusivity for underrepresented groups among eligible applicants, including various educational institutions and nonprofit organizations. Interested parties should submit their applications by January 8, 2025, and can reach out to the NIH OER Webmaster at grantsinfo@nih.gov for further assistance or inquiries regarding the application process.
    NIDA Avant-Garde Program for HIV and Substance Use Disorder Research (DP1 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIDA Avant-Garde Program for HIV and Substance Use Disorder Research, a federal grant opportunity aimed at supporting innovative research proposals that address the intersection of HIV/AIDS and substance use disorders. This program seeks to fund exceptionally creative scientists who can propose high-impact studies that diverge significantly from existing research paths, with a focus on transformative approaches to prevention and treatment. The grant provides funding of up to $700,000 annually for a maximum duration of five years, with a submission deadline of August 14, 2025. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    Research on the Neuro-Immune Axis in the context of HIV and Substance Use (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Research on the Neuro-Immune Axis in the context of HIV and Substance Use," aimed at advancing the understanding of the interplay between neuroimmune networks and the effects of HIV and substance use disorders (SUD). This R01 Clinical Trial Not Allowed grant seeks applications that explore neuroimmune interactions, therapeutic targets, and modulatory tools, with a focus on examining the molecular mechanisms and regulatory pathways influenced by substance use in relation to HIV pathogenesis. The opportunity is significant for addressing HIV-related neurological issues exacerbated by substance abuse, with a total funding of up to $2 million projected for FY 2025 to support up to six projects. Interested applicants must submit their proposals by November 13, 2024, and can find additional information and application instructions at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.